214 related articles for article (PubMed ID: 37968716)
21. Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review.
Keetharuth AD; Hussain H; Rowen D; Wailoo A
Health Qual Life Outcomes; 2022 Sep; 20(1):139. PubMed ID: 36171595
[TBL] [Abstract][Full Text] [Related]
22. Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia.
Michalowsky B; Hoffmann W; Xie F
J Alzheimers Dis; 2021; 83(1):77-87. PubMed ID: 34275901
[TBL] [Abstract][Full Text] [Related]
23. Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia.
Xu RH; Dong D; Luo N; Wong EL; Wu Y; Yu S; Yang R; Liu J; Yuan H; Zhang S
Eur J Health Econ; 2021 Jun; 22(4):547-557. PubMed ID: 33761029
[TBL] [Abstract][Full Text] [Related]
24. Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness.
Bilbao A; García-Pérez L; Arenaza JC; García I; Ariza-Cardiel G; Trujillo-Martín E; Forjaz MJ; Martín-Fernández J
Qual Life Res; 2018 Nov; 27(11):2897-2908. PubMed ID: 29978346
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of PROMIS Preference Scoring System (PROPr) in Patients Undergoing Hemodialysis or Kidney Transplant.
Zhang J; Dewitt B; Tang E; Breitner D; Saqib M; Li D; Siddiqui R; Edwards N; Peipert JD; Hays RD; Hanmer J; Mucsi I
Clin J Am Soc Nephrol; 2021 Sep; 16(9):1328-1336. PubMed ID: 34272256
[TBL] [Abstract][Full Text] [Related]
26. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
27. Comparison between EQ-5D-5L and PROMIS-10 to evaluate health-related quality of life 3 months after stroke: a cross-sectional multicenter study.
DE Graaf JA; Visser-Meily JM; Schepers VP; Baars A; Kappelle LJ; Passier PE; Wermer MJ; DE Wit DC; Post MW
Eur J Phys Rehabil Med; 2021 Jun; 57(3):337-346. PubMed ID: 33448750
[TBL] [Abstract][Full Text] [Related]
28. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
[TBL] [Abstract][Full Text] [Related]
29. Measuring health-related quality of life and well-being: a head-to-head psychometric comparison of the EQ-5D-5L, ReQoL-UI and ICECAP-A.
Xu RH; Keetharuth AD; Wang LL; Cheung AW; Wong EL
Eur J Health Econ; 2022 Mar; 23(2):165-176. PubMed ID: 34338898
[TBL] [Abstract][Full Text] [Related]
30. Psychometric properties of the EQ-5D-5L in the general population of South Korea.
Kim TH; Jo MW; Lee SI; Kim SH; Chung SM
Qual Life Res; 2013 Oct; 22(8):2245-53. PubMed ID: 23224560
[TBL] [Abstract][Full Text] [Related]
31. Validity of EQ-5D-5L in stroke.
Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
[TBL] [Abstract][Full Text] [Related]
32. "The validity of the EQ-5D-5L in measuring quality of life benefits of breast reconstruction".
Kouwenberg CAE; Kranenburg LW; Visser MS; Busschbach JJ; Mureau MAM
J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):52-61. PubMed ID: 30270015
[TBL] [Abstract][Full Text] [Related]
33. Danish population health measured by the EQ-5D-5L.
Jensen MB; Jensen CE; Gudex C; Pedersen KM; Sørensen SS; Ehlers LH
Scand J Public Health; 2023 Mar; 51(2):241-249. PubMed ID: 34847818
[TBL] [Abstract][Full Text] [Related]
34. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi.
Ngwira LG; Maheswaran H; Verstraete J; Petrou S; Niessen L; Smith SC
J Patient Rep Outcomes; 2023 Mar; 7(1):22. PubMed ID: 36892714
[TBL] [Abstract][Full Text] [Related]
35. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
Jankowska A; Młyńczak K; Golicki D
Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
[TBL] [Abstract][Full Text] [Related]
36. A Comparison of a Preliminary Version of the EQ-HWB Short and the 5-Level Version EQ-5D.
Monteiro AL; Kuharic M; Pickard AS
Value Health; 2022 Apr; 25(4):534-543. PubMed ID: 35279371
[TBL] [Abstract][Full Text] [Related]
37. Examining the relationship between the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS) and EQ-5D-5L and comparing their psychometric properties.
Hong Y; Jiang X; Zhang T; Luo N; Yang Z
Health Qual Life Outcomes; 2023 Mar; 21(1):25. PubMed ID: 36927468
[TBL] [Abstract][Full Text] [Related]
38. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
Pattanaphesaj J; Thavorncharoensap M
Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.
Yfantopoulos J; Chantzaras A; Kontodimas S
Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371
[TBL] [Abstract][Full Text] [Related]
40. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
